ABMD Financial Facts

Net loss: 3.84M
Funded research and development: 164K
See Full Income Statement

Cash and cash equivalents: 20.92M
Accumulated deficit: -250.91M
See Full Balance Sheet

Abiomed Inc. (ABMD) Earnings

  |   Expand Research on ABMD
Next EPS Date 1/30/15 *Est. EPS Growth Rate 0.0% *Last Qtr.
Average EPS % Beat Rate +45.6% Revenue Growth Rate +16.9% *Last Qtr.
Average % Move 1-Wk after EPS +9.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/30/14 Q215 $0.03$0.02 +$0.01$51.8M$48.8M N/A Details
7/31/14 Q115 -$0.04N/A N/A $48.8M$297.1M N/A Details
5/1/14 Q414 $0.09$0.08 +$0.01$50.4M$50.93M N/A Details
1/30/14 Q314 $0.11$0.05 +$0.06$46.2M$46M Details
11/6/13 Q214 $0.03$0.00 +$0.03$44.3M$43.75M Details
8/1/13 Q114 -$0.04$0.06 -$0.10$42.7M$42.93M Details
5/2/13 Q413 $0.09$0.07 +$0.02$43.7M$41.95M Details
2/6/13 Q313 $0.07$0.07 $0.00$38.3M$38.04M = Details